• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    CytRx Corporation (CYTR)

    -NasdaqCM
    3.23 Down 0.10(3.00%) Feb 27, 4:00PM EST
    |After Hours : 3.22 Down 0.01 (0.16%) Feb 27, 4:36PM EST
    Add to Portfolio
    Prev Close:3.33
    Open:3.33
    Bid:2.97 x 1400
    Ask:N/A
    1y Target Est:12.00
    Beta:1.07
    Next Earnings Date:N/A
    Day's Range:3.22 - 3.39
    52wk Range:2.08 - 6.46
    Volume:625,055
    Avg Vol (3m):1,328,420
    Market Cap:180.03M
    P/E (ttm):N/A
    EPS (ttm):-0.87
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CYTR

    Comparison

    Symbol% ChgMkt Cap
    CYTRDown 3.00%180.03M
    LLYUp 0.20%74.42B
    NVSDown 0.58%245.62B
    SNYDown 0.02%128.58B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,856.01
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.72
    Quarterly EPS Est (Dec-14) :-0.27
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    CytRx Corporation operates as a biopharmaceutical research and development company specializing in oncology. The company’s product candidate includes aldoxorubicin that has completed Phase IIb clinical trial as a first-line therapy for soft t... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback